1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Monoclonal Antibodies Market, By Source Type
5.1 Introduction
5.2 Humanized
5.3 Chimeric
5.4 Murine
5.5 Human
5.6 Other Source Types
6 Global Monoclonal Antibodies Market, By Production Type
6.1 Introduction
6.2 In Vitro
6.3 In Vivo
7 Global Monoclonal Antibodies Market, By Indication
7.1 Introduction
7.2 Infectious Diseases
7.3 Inflammatory Diseases
7.4 Cancer
7.4.1 Lung cancer
7.4.2 Colorectal cancer
7.4.3 Ovarian cancer
7.4.4 Breast cancer
7.5 Autoimmune Diseases
7.6 Other Indications
8 Global Monoclonal Antibodies Market, By Route of Administration
8.1 Introduction
8.2 Intravitreal
8.3 Subcutaneous
8.4 Intravenous
9 Global Monoclonal Antibodies Market, By Distribution Channel
9.1 Introduction
9.2 Online Pharmacy
9.3 Hospital Pharmacy
9.4 Retail Pharmacy
10 Global Monoclonal Antibodies Market, By Application
10.1 Introduction
10.2 Infectious Diseases
10.3 Neurological Diseases
10.4 Autoimmune Diseases
10.5 Oncology
10.6 Other Applications
11 Global Monoclonal Antibodies Market, By End User
11.1 Introduction
11.2 Specialty Centers
11.3 Hospitals
11.4 Research Institutes
11.5 Other End Users
12 Global Monoclonal Antibodies Market, By Geography
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 New Zealand
12.4.6 South Korea
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Argentina
12.5.2 Brazil
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 Qatar
12.6.4 South Africa
12.6.5 Rest of Middle East & Africa
13 Key Developments
13.1 Agreements, Partnerships, Collaborations and Joint Ventures
13.2 Acquisitions & Mergers
13.3 New Product Launch
13.4 Expansions
13.5 Other Key Strategies
14 Company Profiling
14.1 Johnson & Johnson Services, Inc.
14.2 Viatris Inc.
14.3 Abbott Laboratories
14.4 Eli Lilly And Company
14.5 Bristol-Myers Squibb
14.6 Biogen Inc.
14.7 Merck & Co., Inc.
14.8 Pfizer Inc
14.9 Novartis AG
14.10 Thermo Fisher Scientific, Inc.
14.11 AstraZeneca plc
14.12 GlaxoSmithKline plc
14.13 Novo Nordisk A/S
14.14 Sanofi S.A.
14.15 Merck & Co., Inc.
14.16 Amgen Inc.
14.17 Bayer AG
14.18 Lonza Group
List of Tables
1 Global Monoclonal Antibodies Market Outlook, By Region (2021-2030) ($MN)
2 Global Monoclonal Antibodies Market Outlook, By Source Type (2021-2030) ($MN)
3 Global Monoclonal Antibodies Market Outlook, By Humanized (2021-2030) ($MN)
4 Global Monoclonal Antibodies Market Outlook, By Chimeric (2021-2030) ($MN)
5 Global Monoclonal Antibodies Market Outlook, By Murine (2021-2030) ($MN)
6 Global Monoclonal Antibodies Market Outlook, By Human (2021-2030) ($MN)
7 Global Monoclonal Antibodies Market Outlook, By Other Source Types (2021-2030) ($MN)
8 Global Monoclonal Antibodies Market Outlook, By Production Type (2021-2030) ($MN)
9 Global Monoclonal Antibodies Market Outlook, By In Vitro (2021-2030) ($MN)
10 Global Monoclonal Antibodies Market Outlook, By In Vivo (2021-2030) ($MN)
11 Global Monoclonal Antibodies Market Outlook, By Indication (2021-2030) ($MN)
12 Global Monoclonal Antibodies Market Outlook, By Infectious Diseases (2021-2030) ($MN)
13 Global Monoclonal Antibodies Market Outlook, By Inflammatory Diseases (2021-2030) ($MN)
14 Global Monoclonal Antibodies Market Outlook, By Cancer (2021-2030) ($MN)
15 Global Monoclonal Antibodies Market Outlook, By Lung cancer (2021-2030) ($MN)
16 Global Monoclonal Antibodies Market Outlook, By Colorectal cancer (2021-2030) ($MN)
17 Global Monoclonal Antibodies Market Outlook, By Ovarian cancer (2021-2030) ($MN)
18 Global Monoclonal Antibodies Market Outlook, By Breast cancer (2021-2030) ($MN)
19 Global Monoclonal Antibodies Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
20 Global Monoclonal Antibodies Market Outlook, By Other Indications (2021-2030) ($MN)
21 Global Monoclonal Antibodies Market Outlook, By Route of Administration (2021-2030) ($MN)
22 Global Monoclonal Antibodies Market Outlook, By Intravitreal (2021-2030) ($MN)
23 Global Monoclonal Antibodies Market Outlook, By Subcutaneous (2021-2030) ($MN)
24 Global Monoclonal Antibodies Market Outlook, By Intravenous (2021-2030) ($MN)
25 Global Monoclonal Antibodies Market Outlook, By Distribution Channel (2021-2030) ($MN)
26 Global Monoclonal Antibodies Market Outlook, By Online Pharmacy (2021-2030) ($MN)
27 Global Monoclonal Antibodies Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
28 Global Monoclonal Antibodies Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
29 Global Monoclonal Antibodies Market Outlook, By Application (2021-2030) ($MN)
30 Global Monoclonal Antibodies Market Outlook, By Infectious Diseases (2021-2030) ($MN)
31 Global Monoclonal Antibodies Market Outlook, By Neurological Diseases (2021-2030) ($MN)
32 Global Monoclonal Antibodies Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
33 Global Monoclonal Antibodies Market Outlook, By Oncology (2021-2030) ($MN)
34 Global Monoclonal Antibodies Market Outlook, By Other Applications (2021-2030) ($MN)
35 Global Monoclonal Antibodies Market Outlook, By End User (2021-2030) ($MN)
36 Global Monoclonal Antibodies Market Outlook, By Specialty Centers (2021-2030) ($MN)
37 Global Monoclonal Antibodies Market Outlook, By Hospitals (2021-2030) ($MN)
38 Global Monoclonal Antibodies Market Outlook, By Research Institutes (2021-2030) ($MN)
39 Global Monoclonal Antibodies Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
